Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

HOLD

Has had a tremendous run-up in the last 3/4 weeks. Likes the management and feels the John Hancock acquisition will work out very well. Expects the uptrend will continue.

BUY

Very well-managed. Likes their diversification. Yield is low, but stock could continue going up.

BUY

Has a lot going for it. Likes their far Eastern operations.

BUY

Good management. Expect they will take a lot of costs out of the business with the acquisition of John Hancock. Expecting good Asian growth.

BUY ON WEAKNESS

Should be about to put up some good growth in earnings with their John Hancock acquisition. Expect some selling pressure when Hancock shareholders get their Manulife shares and start selling them. That will be an opportunity to buy.

BUY

Likes the life insurance business, this company in particular. Strong management. Expect they will be ruthless in cutting costs in John Hancock.

BUY

The merger with John Hancock was good and at a reasonable price. This should create cost synergies. Has a strong global presence.

BUY

Likes the insurance industry. Very solid company and well managed. A good hold.

BUY

The Hancock acquisition will add a lot over the next couple of years. Likes their position in Asia as well.

PAST TOP PICK

(A top pick December 16/03. Up 11.5%.) They consolidate very well. Good earnings.

DON'T BUY

Has done a very good job in its acquisition strategy. Will have some digesting problems with the John Hancock acquisition.

BUY

Can go a lot higher now that they John Hancock shareholders have agreed to the sale. Asian assets are now profitable. A good long-term hold.

BUY

Likes the insurance area.

BUY

Not keen on this stock. Feels they are operating in the high risk areas in Asia. Also feels the John Hancock acquisition won't work out as well as expected.

BUY

Was a pullback, because a lot of institutional investors which owned John Hancock word divesting their holdings. Feels the Asian side of the business is the important part.

Showing 2,026 to 2,040 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)